Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Marian L, Kruzel"'
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2429 (2022)
Lung cancer continues to be the deadliest cancer worldwide. A new strategy of combining chemotherapeutics with naturally occurring anticancer compounds, such as lactoferrin, might improve the efficacy and toxicity of current chemotherapy. The aim of
Externí odkaz:
https://doaj.org/article/2cdd9780465d4bcaa0a7c338ba10c1ce
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 898 (2021)
Pregnancy is a physiological state that demands higher level of nutrients, including vitamins and minerals, for the growth and maintenance of the fetus. Iron deficiency is a part of most common diet deficiencies in pregnancy and has high clinical sig
Externí odkaz:
https://doaj.org/article/56e0aa97a40c4e179567df850f04660f
Publikováno v:
BioMetals. 36:603-615
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e86006a80784dc549aa1ddf1f328e31b
https://doi.org/10.1007/s10534-022-00434-0
https://doi.org/10.1007/s10534-022-00434-0
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Much progress has been achieved to elucidate the function of lactoferrin (LTF), an iron-binding glycoprotein, in the milieu of immune functionality. This review represents a unique examination of LTF toward its importance in physiologic homeostasis a
Externí odkaz:
https://doaj.org/article/4c1c3311e7a14d7fabb104b897c2aeb9
Publikováno v:
Biochemistry and Cell Biology. 99:47-53
The immunomodulatory nature of lactoferrin (LF) derives from its ability to bridge innate and adaptive immunity in obtaining physiological equilibrium. LF is an attractive molecule for treatment of diseases that compromise immune homeostasis. Oral de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59fd9cb8dfe550cf5a20243e81e46be0
https://doi.org/10.1139/bcb-2020-0069
https://doi.org/10.1139/bcb-2020-0069
Autor:
John d'Aigle, Marian L. Kruzel, Zainab Niaz, Shen-An Hwang, Thao K.T. Nguyen, Jeffrey K. Actor
Publikováno v:
Biochemistry and Cell Biology. 99:73-80
Primary infection with Mycobacterium tuberculosis (Mtb) results in the formation of a densely packed granulomatous response that essentially limits the entry and efficacy of immune effector cells. Furthermore, the physical nature of the granuloma doe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5ff4587919952687fd1240b6deecbfd
https://doi.org/10.1139/bcb-2020-0057
https://doi.org/10.1139/bcb-2020-0057
Publikováno v:
Biochemistry and Cell Biology. 99:97-101
In this minireview we discuss the role of lactoferrin (LTF) in detoxifying hematoma after intracerebral hemorrhage (ICH). Subsequent to ICH, neutrophils enter the ICH-affected brain, where they release various granule contents, including LTF. LTF is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f5224607f341ceab2cd26c7e704e6c
https://doi.org/10.1139/bcb-2020-0116
https://doi.org/10.1139/bcb-2020-0116
Autor:
Ewa Zaczyńska, Maja Kocięba, Jolanta Artym, Iwona Kochanowska, Marian L. Kruzel, Michał Zimecki
Publikováno v:
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine.
Lactoferrin (LTF) is a natural iron-binding protein with a potential for clinical utility in many human immune disorders, including cancer. A fusion of LTF with the Fc domain of IgG2 (FcLTF) was designed with inherent properties of an extended the ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d9cd379c4a6df66e4b17afc0b0125eb
https://pubmed.ncbi.nlm.nih.gov/36136256
https://pubmed.ncbi.nlm.nih.gov/36136256
Publikováno v:
Archivum Immunologiae et Therapiae Experimentalis. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f554e38ee5856dd9723e76a8bf4502e9
https://doi.org/10.1007/s00005-022-00648-7
https://doi.org/10.1007/s00005-022-00648-7
Publikováno v:
Archivum Immunologiae et Therapiae Experimentalis
Lung cancer remains the leading cause of cancer death worldwide. Despite the recent advances in cancer treatment, only a subset of patients responds to targeted and immune therapies, and many patients developing resistance after an initial response.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66f2bc89c277c99dd7701a60c49f3296
https://doi.org/10.1007/s00005-021-00637-2
https://doi.org/10.1007/s00005-021-00637-2